Aresta et al., 2024 - Google Patents
Analysis and characterization of the extracellular vesicles released in non-cancer diseases using matrix-assisted laser desorption ionization/mass spectrometryAresta et al., 2024
View HTML- Document ID
- 15310728312649197144
- Author
- Aresta A
- De Vietro N
- Zambonin C
- Publication year
- Publication venue
- International Journal of Molecular Sciences
External Links
Snippet
The extracellular vesicles (EVs) released by cells play a crucial role in intercellular communications and interactions. The direct shedding of EVs from the plasma membrane represents a fundamental pathway for the transfer of properties and information between …
- 238000000816 matrix-assisted laser desorption--ionisation 0 title abstract description 44
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Muraoka et al. | Proteomic profiling of extracellular vesicles derived from cerebrospinal fluid of Alzheimer’s disease patients: a pilot study | |
| Zebrowska et al. | Metabolome of exosomes: Focus on vesicles released by cancer cells and present in human body fluids | |
| Kawashima et al. | Optimization of data-independent acquisition mass spectrometry for deep and highly sensitive proteomic analysis | |
| Askeland et al. | Mass-spectrometry based proteome comparison of extracellular vesicle isolation methods: comparison of ME-kit, size-exclusion chromatography, and high-speed centrifugation | |
| Trifonova et al. | Evaluation of dried blood spot sampling for clinical metabolomics: effects of different papers and sample storage stability | |
| Duarte et al. | Personalized proteomics: the future of precision medicine | |
| Yilmaz et al. | Targeted metabolic profiling of urine highlights a potential biomarker panel for the diagnosis of Alzheimer’s disease and mild cognitive impairment: a pilot study | |
| Mun et al. | Proteomics approach for the discovery of rheumatoid arthritis biomarkers using mass spectrometry | |
| Ravishankar et al. | Tears as the next diagnostic biofluid: a comparative study between ocular fluid and blood | |
| Di Girolamo et al. | A sensitive and effective proteomic approach to identify she-donkey’s and goat’s milk adulterations by MALDI-TOF MS fingerprinting | |
| Aresta et al. | Analysis and characterization of the extracellular vesicles released in non-cancer diseases using matrix-assisted laser desorption ionization/mass spectrometry | |
| Liao et al. | Urinary proteomics for the early diagnosis of diabetic nephropathy in Taiwanese patients | |
| Lai et al. | Protein panel of serum-derived small extracellular vesicles for the screening and diagnosis of epithelial ovarian cancer | |
| Hosseinkhani et al. | Towards standards for human fecal sample preparation in targeted and untargeted lc-hrms studies | |
| Cho et al. | Separation of permethylated O-glycans, free oligosaccharides, and glycosphingolipid-glycans using porous graphitized carbon (PGC) column | |
| Sjoqvist et al. | Analysis of cerebrospinal fluid extracellular vesicles by proximity extension assay: A comparative study of four isolation kits | |
| Jeong et al. | GCC2 as a new early diagnostic biomarker for non-small cell lung cancer | |
| Matthiesen et al. | Extracellular vesicles in diffuse large B cell lymphoma: characterization and diagnostic potential | |
| Zhang et al. | Proteomics, phosphoproteomics and mirna analysis of circulating extracellular vesicles through automated and high-throughput isolation | |
| Florens et al. | Proteomic characterization of high-density lipoprotein particles from non-diabetic hemodialysis patients | |
| Park et al. | Multiple-cycle polymeric extracellular vesicle precipitation and its evaluation by targeted mass spectrometry | |
| Cho et al. | N-glycomics of cerebrospinal fluid: method comparison | |
| Nedelkov | Mass spectrometric studies of apolipoprotein proteoforms and their role in lipid metabolism and type 2 diabetes | |
| Azkargorta et al. | Human serum extracellular vesicle proteomic profile depends on the enrichment method employed | |
| Pirro et al. | Oxonium ion guided analysis of quantitative proteomics data reveals site-specific O-glycosylation of anterior gradient protein 2 (AGR2) |